Wilfried Moreira

741 total citations
16 papers, 571 citations indexed

About

Wilfried Moreira is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Wilfried Moreira has authored 16 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Wilfried Moreira's work include Tuberculosis Research and Epidemiology (5 papers), Mycobacterium research and diagnosis (3 papers) and Peptidase Inhibition and Analysis (3 papers). Wilfried Moreira is often cited by papers focused on Tuberculosis Research and Epidemiology (5 papers), Mycobacterium research and diagnosis (3 papers) and Peptidase Inhibition and Analysis (3 papers). Wilfried Moreira collaborates with scholars based in Singapore, United States and Canada. Wilfried Moreira's co-authors include Thomas Dick, Marc Ouellette, Dinah B. Aziz, Philippe Leprohon, Tianming Yang, Huan Chen, Mei‐Lin Go, Éric Leblanc, Brian Dymock and Grace Ngan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Wilfried Moreira

16 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wilfried Moreira Singapore 12 250 196 157 129 125 16 571
Benjamin Blasco Switzerland 11 210 0.8× 177 0.9× 230 1.5× 70 0.5× 347 2.8× 15 707
Lucimar F. Kneipp Brazil 17 207 0.8× 400 2.0× 323 2.1× 107 0.8× 93 0.7× 31 734
Diego de Souza Gonçalves Brazil 12 162 0.6× 216 1.1× 220 1.4× 35 0.3× 76 0.6× 28 476
Saradee Warit Thailand 12 266 1.1× 205 1.0× 311 2.0× 102 0.8× 96 0.8× 30 608
Dalia Denapaite Germany 15 551 2.2× 476 2.4× 184 1.2× 81 0.6× 232 1.9× 25 1.2k
Wim van Vianen Netherlands 18 191 0.8× 247 1.3× 276 1.8× 35 0.3× 85 0.7× 26 763
James C. Levin United States 7 214 0.9× 105 0.5× 340 2.2× 131 1.0× 349 2.8× 8 777
Daniel Llull Spain 14 286 1.1× 321 1.6× 86 0.5× 72 0.6× 155 1.2× 19 763
Vickie Brown‐Driver United States 13 484 1.9× 209 1.1× 228 1.5× 117 0.9× 25 0.2× 14 863
Katharine C. Carter United Kingdom 14 225 0.9× 145 0.7× 75 0.5× 90 0.7× 150 1.2× 24 773

Countries citing papers authored by Wilfried Moreira

Since Specialization
Citations

This map shows the geographic impact of Wilfried Moreira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilfried Moreira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilfried Moreira more than expected).

Fields of papers citing papers by Wilfried Moreira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilfried Moreira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilfried Moreira. The network helps show where Wilfried Moreira may publish in the future.

Co-authorship network of co-authors of Wilfried Moreira

This figure shows the co-authorship network connecting the top 25 collaborators of Wilfried Moreira. A scholar is included among the top collaborators of Wilfried Moreira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilfried Moreira. Wilfried Moreira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Liu, Yang, et al.. (2025). Clinical application of customized and non-customized bacteriophage therapy in patients with refractory/resistant bacterial infections: A systematic review and meta-analysis. International Journal of Antimicrobial Agents. 66(4). 107570–107570. 1 indexed citations
2.
Farkas, Eszter, Geoffrey A. McKay, Lin Hu, et al.. (2024). Bioluminescent Pseudomonas aeruginosa and Escherichia coli for whole-cell screening of antibacterial and adjuvant compounds. Scientific Reports. 14(1). 31039–31039. 2 indexed citations
3.
Ho, Peiying, Chia Ching Chan, Thet Tun Aung, et al.. (2024). Screening of the PA14NR Transposon Mutant Library Identifies Genes Involved in Resistance to Bacteriophage Infection in Pseudomomas aeruginosa. International Journal of Molecular Sciences. 25(13). 7009–7009. 3 indexed citations
4.
Ding, Xin, Chuan Yang, Wilfried Moreira, et al.. (2020). Antibiotic Resistance: A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics (Adv. Sci. 17/2020). Advanced Science. 7(17). 2 indexed citations
5.
Sinha, Ameya, Jacqueline Chen, Jiaqi Liang, et al.. (2020). Hydrogen Sulfide Sensitizes Acinetobacter baumannii to Killing by Antibiotics. Frontiers in Microbiology. 11. 1875–1875. 19 indexed citations
6.
Ding, Xin, Chuan Yang, Wilfried Moreira, et al.. (2020). A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics. Advanced Science. 7(17). 2001374–2001374. 95 indexed citations
7.
Chen, Huan, Ming Li, Pooja Gopal, et al.. (2018). The Mycobacterial Membrane: A Novel Target Space for Anti-tubercular Drugs. Frontiers in Microbiology. 9. 1627–1627. 44 indexed citations
8.
Moreira, Wilfried, et al.. (2017). Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome. Frontiers in Microbiology. 8. 746–746. 18 indexed citations
9.
Moreira, Wilfried, Grace Ngan, Kanda Sangthongpitag, et al.. (2017). Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome. Antimicrobial Agents and Chemotherapy. 61(5). 25 indexed citations
10.
Yang, Tianming, Wilfried Moreira, Huan Chen, et al.. (2017). Amphiphilic Indole Derivatives as Antimycobacterial Agents: Structure–Activity Relationships and Membrane Targeting Properties. Journal of Medicinal Chemistry. 60(7). 2745–2763. 66 indexed citations
11.
Moreira, Wilfried, Dinah B. Aziz, & Thomas Dick. (2016). Boromycin Kills Mycobacterial Persisters without Detectable Resistance. Frontiers in Microbiology. 7. 199–199. 63 indexed citations
12.
Moreira, Wilfried, et al.. (2016). Fragment-Based Whole Cell Screen Delivers Hits against M. tuberculosis and Non-tuberculous Mycobacteria. Frontiers in Microbiology. 7. 17 indexed citations
13.
Moreira, Wilfried, Grace Ngan, Anders Poulsen, et al.. (2015). Target Mechanism-Based Whole-Cell Screening Identifies Bortezomib as an Inhibitor of Caseinolytic Protease in Mycobacteria. mBio. 6(3). e00253–15. 86 indexed citations
14.
Moreira, Wilfried, Danielle Légaré, Gina Racine, Gaétan Roy, & Marc Ouellette. (2014). Proteomic analysis of metacyclogenesis in Leishmania infantum wild-type and PTR1 null mutant. SHILAP Revista de lepidopterología. 4. 171–183. 12 indexed citations
15.
Moreira, Wilfried, Philippe Leprohon, & Marc Ouellette. (2011). Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania. Cell Death and Disease. 2(9). e201–e201. 83 indexed citations
16.
Moreira, Wilfried, Éric Leblanc, & Marc Ouellette. (2008). The role of reduced pterins in resistance to reactive oxygen and nitrogen intermediates in the protozoan parasite Leishmania. Free Radical Biology and Medicine. 46(3). 367–375. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026